Morning Briefing
Summaries of health policy coverage from major news organizations
FDA Drafts New Rules For Testing, Approving Drug Cocktails; Public-Private Partnership For TB Treatment Development Launched
The FDA is drafting new guidelines for testing and approving multidrug cocktails for life-threatening diseases, the Wall Street Journal reports. "Many diseases, such as AIDS, tuberculosis and cancer, require multidrug combinations. Such drug cocktails can prevent the development of drug resistance, because the microbe or cancer cell needs to undergo more mutations to escape several drugs than to escape just one. By attacking the disease in different ways, drug combinations also improve the chances of therapeutic benefit," the newspaper reports (Schoofs, 3/18).
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
